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Fast inactivationThe substituted-cysteine scanning method (SCAM) is used to study conformational changes in proteins. Ex-
periments using SCAM involve site-directed mutagenesis to replace native amino acids with cysteine and
subsequent exposure to a methanethiosulfonate (MTS) reagent such as methanethiosulfonate ethylammo-
nium (MTSEA). These reagents react with substituted-cysteines and can provide functional information
about relative positions of amino acids within a protein. In the human heart voltage-gated Na+ channel
hNav1.5 there is a native cysteine at position C373 that reacts rapidly with MTS reagents resulting in a
large reduction in whole-cell Na+ current (INa). Therefore, in order to use SCAM in studies in this isoform,
this native cysteine is mutated to a non-reactive residue, e.g., tyrosine. This mutant, hNav1.5-C373Y, is resis-
tant to the MTS-mediated decrease in INa. Here we show that this resistance is time- and state-dependent.
With relatively short exposure times to MTSEA (b4 min), there is little effect on INa. However, with longer ex-
posures (4–8 min), there is a large decrease in INa, but this effect is only found when hNav1.5-C373Y is
inactivated (fast or slow) — MTSEA has little effect in the closed state. Additionally, this long-term, state-
dependent effect is not seen in human skeletal muscle Na+ channel isoform hNav1.4, which has a native
tyrosine at the homologous site C407. We conclude that differences in molecular determinants of inactivation
between hNav1.4 and hNav1.5 underlie the difference in response to MTSEA exposure.
© 2011 Elsevier B.V. All rights reserved.1. Introduction
The substituted-cysteine scanning method (SCAM) can be used to
study conformational changes in proteins [1]. Experiments using
SCAM involve site-directed mutagenesis to replace native amino
acids with cysteine and subsequent exposure to a methanethiosulfo-
nate (MTS) reagent such as methanethiosulfonate ethylammonium
(MTSEA). If the substituted cysteine is “accessible” to the applied
MTS reagent, its sulfhydral side chain (\SH) can form a covalent di-
sulﬁde bond with sulfur in the MTS reagent. If this reaction produces
a measurable effect on the function of the protein of interest (e.g.,
changes in current responses to voltage stimuli in voltage-gated ion
channels) then conclusions about protein conformation can be made.
During SCAM experiments, we and others have previously shown
that the wild-type human heart isoform of the voltage-gated Na
channel (hNav1.5) responds rapidly with a decrease in whole-cell
current (INa) when exposed to extracellular methanethiosulfonate
(MTS) reagents [2,3]. This rapid response (seconds) is eliminated
with site-directed mutagenesis replacing cysteine at site C373 in the+1 985 549 3851.
hockett@selu.edu
rights reserved.outer pore of wild-type hNav1.5, e.g., with tyrosine in hNav1.5-
C373Y [2,3]. Interestingly, the C373Y site mutation in hNav1.5-
C373Y is analogous to the MTS-resistant skeletal muscle Na channel
hNav1.4 [2], in which tyrosine is found at the C373-homologous site
(Y401 in rat Nav1.4, Y407 in human Nav1.4). The C373 site in
hNav1.5 is also of interest because this is the site that renders
hNav1.5 resistant to tetrodotoxin (TTX) block, a resistance that is
abolished with the same C to Y substitution as above [3,4].
While studies with SCAM often ﬁnd effects within a relatively short
MTS exposure time (seconds to minutes), there is little information
about effects of longer MTS exposure times, e.g., >4 min. In this study,
we characterize the effects of long-term exposure (up to 8 min) of
hNav1.5-C373Y to extracellular MTSEA. While≈4 min of MTSEA expo-
sure results in little effect on INa in hNav1.5-C373Y, whether in the
closed, fast-inactivated, or slow-inactivated state [2,3], we demonstrate
here that exposure to MTSEA for greater than 4 min produces a signiﬁ-
cant reduction in current in this mutant. However, this effect only oc-
curs when the channels are in an inactivated state (slow or fast),
demonstrating that this effect is both time- and state-dependent.
Additionally, while hNav1.5-C373Y responds to MTSEA in a time- and
state-dependent manner, the skeletal muscle isoform hNav1.4 does
not, suggesting that there are isoform speciﬁc structural determinants
of inactivation that underlie this difference.
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2.1. Site-directed mutagenesis
Site-directed mutagenesis to produce hNav1.5-C373Y was carried
out using a modiﬁcation of a 2-stage modiﬁcation of the Quick Change
XL Site directed Mutagenesis Kit protocol as previously described [2].
2.2. Transient transfection
Plasmid expression constructs containing wild-type hNav1.4, wild-
type hNav1.5, and mutant hNav1.5-C373Y cDNA clones (10 μg) were
transiently transfected into HEK cells using calcium phosphate precipi-
tation as previously described [5,6]. The transfection solution included
2 μg of a plasmid encoding cell surface antigen CD8 (OriGene, Rockville,
MD,USA) and cellswere selected for recording based on positive immu-
noreaction with anti-CD8 Dynabeads (Invitrogen).
2.3. Electrophysiology
Using standard patch clamp techniques [7], we recorded whole-
cell Na+ current (INa) from wild-type hNav1.4, wild-type hNav1.5,
and mutant hNav1.5-C373Y in transiently transfected HEK cells. Re-
cordings were performed at room temperature (20–22 °C) and were
initiated ≈5 min after whole-cell recording was established unless
otherwise noted. Glass micropipettes (Drummond Scientiﬁc, Broo-
mall, PA, USA) were pulled on a Model P-97 Flaming-Brown puller
(Sutter Instruments, Novato, CA, USA) and had resistances from 0.5
to 1.5 MΩ. The recording solutions in mM were: extracellular — 65
NaCl, 85 choline-Cl, 2 CaCl2, and 10 HEPES, titrated to pH 7.4 with
TMA-OH; intracellular— 100 NaF, 30 NaCl, 10 EGTA, and 10 HEPES, ti-
trated to pH 7.2 with CsOH. The advantage of the outward Na+ gradi-
ent has been presented previously [8]. During recordings, the cells
were continuously bathed with extracellular solution via a gravity-
fed superfusion system at a rate of approximately 0.1–0.2 ml/min.
For all recordings, series resistance was compensated at 80% and
leak currents were subtracted based on ﬁve hyperpolarizing pulses.
Any endogenous K+ currents were blocked with Cs+ in the pipette,
and HEK cells express no native Ca++ current [9]. Recordings were
performed 1 to 3 days post-transfection. The holding potential
(Vhold) for all experiments was −160 mV. A test pulse to +50 mV
(4 or 6 ms) was used to record peak available Na+ current (INa).
2.4. Application of cysteine modiﬁcation agent methanethiosulfonate
ethylammonium (MTSEA)
The cysteine modiﬁcation agent MTSEA (Toronto Research Chemi-
cals, Toronto, Ontario, Canada) was dissolved in water (15 mM) on
the day of the experiment and kept on ice in the dark before ﬁnal di-
lution into extracellular solution to 1.5 mM immediately prior to use.
MTSEA was applied extracellularly via the gravity fed superfusion
system. We used MTSEA and extracellular application because
MTSEA can enter and cross the membrane and access transmembrane
and intracellular protein sites [10].
For intracellular application, MTSEA was included in the pipette
solution. Because this method essentially exposes the channels to
MTSEA once whole-cell access has been established, it is not possible
to absolutely control the start and stop of MTSEA exposure, and the
data is difﬁcult to directly compare with results from extracellular ap-
plication, where exposure time is more easily and accurately con-
trolled. Also, MTSEA exposure (extracellular or intracellular) of
longer than 10 min often resulted in a degradation of cell morpholo-
gy, increased holding current, and loss of electrical recording. We
believe that this toxic effect of MTSEA is probably due to its accumu-
lation in the membrane and subsequent disruption of membrane
integrity.We performed additional experiments using the membrane-
impermeant MTS-reagent methanethiosulfonate ethyltrimethylammo-
nium (MTSET), which, interestingly, was much better tolerated by the
HEK cells (e.g., good cell morphology and stable holding current for
20 min or more) compared with MTSEA. We used MTSET in an effort
to determine if any effects depended on which side of the membrane
the MTS reagent was applied.
MTS modiﬁcation was determined by monitoring effects on whole-
cell current with a 4- or 6-ms test pulse to +50mV. In all protocols, the
test pulse was immediately preceded by a 100-ms step to−180 mV to
minimize potential effects of voltage shifts in fast inactivation. For
closed-state accessibility the test pulse was from Vhold every 40 s. For
fast-inactivated state accessibility, we used a 30-s train of 100 ms depo-
larizing pulses to 0 mVwith 100-ms repolarization between each pulse,
then 10-s at Vhold, then the test pulse. We also used a train with 10-ms
depolarizations to 0 mV, with a 40-ms repolarization between each
pulse, followed by the 10-s at Vhold prior to the test pulse. The data
from these two protocols were not different and were pooled for anal-
ysis. For slow-inactivated state accessibility we used a 30-s prepulse
to 0 mV and a 10-s interpulse to Vhold before each test pulse. For extra-
cellular MTSEA or MTSET, currents were normalized to the test pulse
immediately preceding the onset of MTS application.
2.5. Data collection and analysis
Data were collected using an Axopatch 200B ampliﬁer (ﬁltered at
5 kHz) and pCLAMP 10 software (Molecular Devices, Sunnyvale, CA,
USA). Analysis of data was performed with pCLAMP and Origin soft-
ware (MICROCAL Software, Inc., Northampton, MA, USA). Differences
were considered signiﬁcant at pb0.05 (ANOVA). Grouped data are
presented as mean±S.E.M.
3. Results
3.1. In the closed state, hNav1.5-C373Y is resistant to time-dependent
MTSEA-mediated decrease in whole cell Na+ current (INa)
We characterized the baseline electrophysiology of the mutant
hNav1.5-C373Y in a previous study [2]. This mutant, with a tyrosine
(Y) substituted for a cysteine (C) in the outer pore region, is used
for MTS studies because the native C373 in wild-type hNav1.5 reacts
rapidly (seconds) with MTS reagents when in the closed state, which
greatly reduces INa (by 50.3±0.1% at 40 s, and 85.3±0.02% at 120 s,
n=4; Fig. 1) [2,3]. This response also occurs when wild-type
hNav1.5 is in the fast inactivated (reduced by 87.1±0.01% at 120 s,
n=3) or slow inactivated (reduced by 85.3±0.02% at 120 s, n=3)
states (data not shown). Substitution of tyrosine at C373 in
hNav1.5-C373Y eliminates this rapid response to MTS reagents [2,3]
and INa is only slightly decreased even after 8 min of MTSEA exposure
in the closed state (by 11.5±0.02%; n=12; Fig. 1). Tyrosine was cho-
sen because this is the residue at the homologous site Y407 in the
human skeletal muscle isoform hNav1.4, which is resistant to the
MTSEA-mediated reduction in INa (7.5±0.02% at 8 min, n=4; Fig. 1).
Intracellular exposure of hNav1.5-C373Y to MTSEA in the closed
state produced a modest decrease in INa over 8 min of whole-cell re-
cording (21.6±0.1% reduction, n=5; data not shown). These data
were normalized to a test pulse≈30 s after rupture of the membrane.
3.2. In the inactivated state, but not the closed state, long-term MTSEA
exposure (8 min) reduces INa in hNav1.5-C373Y
In our previous study, the hNav1.5-C373Y mutant was exposed to
MTSEA for a relatively short 4 min in the closed, fast-inactivated, or
slow-inactivated state with little effect [2]. Here we show that a lon-
ger exposure time to extracellular MTSEA (8 min) in hNav1.5-C373Y
produces a signiﬁcant decrease in INa in a state-dependent manner
Fig. 1. The rapid response to MTSEA in wild-type hNav1.5 is eliminated in the mutant
hNav1.5-C373Y. The effect is not seen in wild-type hNav1.4. The cells were exposed to
MTSEA at Vhold of −160 mV (closed state) with a test pulse to +50 mV every 40 s. In-
sets, representative traces. Scale bars, 2 nA, 1 ms.
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hNav1.5-C373Y is in the closed state (see Section 3.1, Fig. 1, Fig. 2),
this effect is seen when hNav1.5-C373Y is fast-inactivated or slow-
inactivated (reduced by 51.9±0.06% at 8 min, n=8, and 47.8±
0.05% at 8 min, n=14, respectively; pb0.001 compared with closed
state; Fig. 2). Additionally, the reduction in INa is not reversed by
washout of MTSEA (Fig. 2), suggesting that the effect is due to direct
MTSEA covalent bonding to the channels, and not the result of an in-
direct, non-speciﬁc effect.
Although it is more difﬁcult to control exposure time with intra-
cellular application via inclusion in the recording pipette, we did ob-
serve that intracellular MTSEA exposure over 8 min reduced INa when
the channels were fast-inactivated or slow-inactivated (by 49.1±
0.01%, n=3, and 46.3±0.07%, n=5, respectively; data not shown).
The inactivation data were normalized to a test pulse immediately
prior to the beginning of the inactivation protocols, which startedFig. 2. MTSEA exposure >4 min decreases whole cell current when hNav1.5-C373Y is
in the inactivated state (fast or slow). For closed-state accessibility, a test pulse
(+50 mV) from Vhold (−160 mV) every 40 s. For fast-inactivated state accessibility, a
30-s train of 100 ms depolarizing pulses to 0 mV with 100-ms repolarization between
each pulse, then 10 s at Vhold, then the test pulse, or a train with 10-ms depolarizations
to 0 mV, with a 40-ms repolarization between each pulse, followed by 10 s at Vhold
prior to the test pulse. For slow-inactivated state accessibility, a 30-s prepulse to
0 mV and a 10-s interpulse to Vhold before each test pulse. Inset, representative traces.
Scale bars, 2 nA, 1 ms.around 1–2 min after going whole-cell, i.e., total MTSEA exposure
time for the intracellular inactivation experiments totaled 8 min,
with ≈1–2 min in the closed state before beginning the inactivation
protocols.
3.3. Methanethiosulfonate ethyltrimethylammonium (MTSET) does not
produce the time- and state-dependent effect seen with MTSEA
We also performed these experiments with 8 min of extracellular
exposure to methanethiosulfonate ethyltrimethylammonium
(MTSET), which does not cross the membrane and is “bulkier” than
MTSEA [11]. With extracellular application of MTSET, we found no
signiﬁcant reduction in INa in the closed (8.8±0.03%, n=5), fast-
inactivated (10.8±0.05%, n=4), or slow-inactivated (8.8±0.03%,
n=5) states (data not shown). Inclusion of MTSET in the pipette
also did not show the reduction in INa (closed, 8.1±0.04%, n=3;
fast-inactivated, 12.6±0.03%, n=7; slow-inactivated, 5.8±0.03%,
n=4; data not shown).
3.4. Four minutes of MTSEA exposure in the closed state is sufﬁcient to al-
low for the state-dependent reduction of INa in hNav1.5-C373Y
To ask whether the long-term, MTSEA-mediated effect was depen-
dent on the kinetic state of hNav1.5-C373Y during the entire exposure
time of 8 min, we exposed hNav1.5-C373Y to MTSEA for 4 min while
in the closed state, and then, with the continuous ﬂow of MTSEA, put
hNav1.5-C373Y into either the fast- or slow-inactivated state for an ad-
ditional 4 min (total of 8 min MTSEA exposure). We reasoned that this
would help determine whether hNav1.5-C373Y must be in an inacti-
vated state the whole time for the effect to occur, or whether the effect
becomes evident once MTSEA reaches the site of modiﬁcation. The re-
sults are shown in Fig. 3. While there is little reduction in INa during
the ﬁrst 4 min in the closed state (8.1±0.01%), once hNav1.5-C373Y
is inactivated (fast or slow) after the ﬁrst 4 min of MTSEA, there is a
rapid and sharp reduction in INa over the next 4 min (fast-inactivated
by 61.4±0.04% at 8 min, n=4, and slow-inactivated by 61.6±0.04%
at 8 min, n=5; pb0.001 for both compared with closed state; Fig. 3).Fig. 3. MTSEA effect is not dependent on kinetic state during the ﬁrst 4 min of expo-
sure. Cells were exposed to MTSEA for 4 min in the closed state and then put in an inac-
tivated state (fast or slow) for 4 additional minutes (total exposure of 8 min). Once the
cells are inactivated, there is a large and rapid decrease in current in response to
MTSEA. For closed-state accessibility, a test pulse (+50 mV) from Vhold (−160 mV)
every 40 s. For fast-inactivated state accessibility, a 30-s train of 100 ms depolarizing
pulses to 0 mV with 100-ms repolarization between each pulse, then 10 s at Vhold,
then the test pulse, or a train with 10-ms depolarizations to 0 mV, with a 40-ms repo-
larization between each pulse, followed by 10 s at Vhold prior to the test pulse. For slow-
inactivated state accessibility, a 30-s prepulse to 0 mV and a 10-s interpulse to Vhold be-
fore each test pulse. Inset, representative traces. Scale bars, 2 nA, 1 ms.
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pendent of the kinetic state with regard to producing the MTSEA-
mediated effect. Because there is no effect during the initial 4 min re-
gardless of kinetic state [2], this suggests that it takes about 4 min for
the MTSEA to get to the site of modiﬁcation, and that hNav1.5-C373Y
must be inactivated for the effect to take place after this time.
3.5. The time- and state-dependent MTSEA-mediated reduction of INa
seen in hNav1.5-C373Y does not occur in hNav1.4
The long-term (8 min), inactivation-dependent effect of extracel-
lular MTSEA observed in hNav1.5-C373Y is not seen in wild-type
human skeletal muscle Na channel hNav1.4 when compared with
hNav1.5-C373Y. In fast-inactivated hNav1.4, INa was reduced by
21.3±0.05%, compared with 51.9% in fast-inactivated hNav1.5-
C373Y (n=5; pb0.01; Fig. 4). In slow-inactivated hNav1.4, INa was
reduced by 16.8±0.06% compared with 47.8% in slow-inactivated
hNav1.5-C373Y (n=8; pb0.001; Fig. 4). This suggests that there are
isoform-speciﬁc differences in molecular determinants of inactivation
between these two isoforms that mediate the differential MTSEA
effect.
4. Discussion
We have shown that relatively long exposure to MTSEA (8 min)
reduces INa in the modiﬁed heart Na+ channel hNav1.5-C373Y in a
state- and time-dependent manner, and that this effect is not seen
in the hNav1.4 skeletal muscle isoform.
4.1. Time-dependence of MTSEA effect in hNav1.5-C373Y
Our previous work demonstrated resistance to MTSEA in hNav1.5-
C373Y with exposure of 4 min [2]. Here we ﬁnd that continuing the
MTSEA exposure up to 8 min produces a signiﬁcant reduction in INa
in this mutant, but only when hNav1.5-C373Y is in an inactivated
state (fast or slow). This effect is not found when hNav1.5-C373Y is
in the closed state. We attribute this long-term effect to a time-
dependent diffusion of MTSEA to an undetermined molecular site,
presumably a cysteine residue(s), where it would produce this effect.Fig. 4. The inactivation-dependent, MTSEA-mediated reduction of current is not found
in hNav1.4. The data for C373Y (line graphs) and closed hNav1.4 are from Fig. 2. For
closed-state accessibility, a test pulse (+50 mV) from Vhold (−160 mV) every 40 s.
For fast-inactivated state accessibility, a 30-s train of 100 ms depolarizing pulses to
0 mV with 100-ms repolarization between each pulse, then 10 s at Vhold, then the
test pulse, or a train with 10-ms depolarizations to 0 mV, with a 40-ms repolarization
between each pulse, followed by 10 s at Vhold prior to the test pulse. For slow-
inactivated state accessibility, a 30-s prepulse to 0 mV and a 10-s interpulse to Vhold be-
fore each test pulse. Inset, representative traces. Scale bars, 2 nA, 1 ms.Additional experiments with the membrane-impermeant MTSET did
not produce the effect when applied extracellularly, suggesting that
the MTSEA-mediated reduction in INa is dependent on MTSEA's ability
to enter and/or cross the membrane [2,10].
We also performed experiments with MTS reagents included in
the recording pipette, thereby exposing the intracellular side of the
channels to MTS. Although it is difﬁcult to accurately control the
time of exposure to MTS with this method, we obtained similar re-
sults as with extracellular application. That is, MTSEA reduced INa in
the inactivated states, while MTSET did not. The reagent MTSET is
membrane impermeant and is often used to determine accessibility
from one side of the membrane or the other [10,12,13]. Therefore,
the intracellular MTSET results suggest that the site of modiﬁcation
is not found in the intracellular portions of the channels. However,
calculated molecular dimensions compute the volume of MTSET at
173 Å3 and MTSEA at 113 Å3 [11]. Therefore, another possibility
would be that MTSET is too “bulky” to gain access to sites of modiﬁca-
tion. In contrast, MTSEA, which is smaller and membrane permeant,
can more easily diffuse to protein modiﬁcation sites, whether at intra-
cellular regions, transmembrane segments, or pore areas of the chan-
nels [10,11]. The difference between MTSEA and MTSET would also
suggest that MTSEA can illuminate potentially signiﬁcant molecular
rearrangements during inactivation processes that are not evident
with MTSET application.4.2. State-dependence of long-term MTSEA effect in hNav1.5-C373Y —
fast and slow inactivation
An interest in slow inactivation is what originally led us to uncov-
er the effect of relatively long exposure to MTSEA in hNav1.5-C373Y.
Initial experiments using slow inactivation protocols demonstrated
state-dependence of long-term MTSEA exposure, i.e., it occurred in
the slow-inactivated state, but not the closed state. During control ex-
periments, we also discovered that this long-term effect occurs when
hNav1.5-C373Y is fast inactivated. One interpretation of this result is
that because fast inactivation occurs ﬁrst, then channels that are slow
inactivated are potentially also still fast inactivated. Therefore, the
MTSEA effect during the slow inactivation protocol may simply reﬂect
an earlier fast-inactivation modiﬁcation, and no further effect result-
ing from entry into the slow-inactivated state. This interpretation is
consistent with results from studies demonstrating that disruption
of fast inactivation in voltage-gated Na+ channels does not eliminate
slow inactivation, suggesting that fast and slow inactivation occur via
different molecular mechanisms and are distinct inactivation states
[14–17]. However, these same studies showed that disruption or re-
moval of fast inactivation accelerates slow inactivation, suggesting
that these processes are “linked” or “coupled” and hence share molec-
ular determinants [14–17]. Hence, it would not be surprising if the
MTSEA-mediated effect in fast- and slow-inactivated hNav1.5-
C373Y in this study share molecular components, and that the
inactivation-dependence of the MTSEA effect is mediated by confor-
mational determinants that are common to both fast and slow
inactivation.
A possible way to look at coupling, or lack thereof, between fast
and slow inactivation would be to create mutants in which inactiva-
tion (fast or slow) is disrupted, and to expose these mutants to
MTSEA. For example, a mutant with disrupted fast inactivation (but
with normal slow inactivation kinetics) may show a diminished re-
sponse to MTSEA when fast inactivated, but without any change in
the response during slow inactivation. A conclusion from such an ex-
periment would be that MTSEA produces the same effect (decreased
INa) during inactivation (either fast or slow), but that there are dis-
tinct molecular rearrangements and modiﬁcations associated with
each state, each of which could react with MTSEA and reduce INa. Al-
ternatively, if the mutant also shows a reduced response to MTSEA
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determinant common to both fast and slow inactivation.
While we believe that the MTSEA-mediated reduction in INa is
probably due to modiﬁcation of mechanism(s) of inactivation, an al-
ternative explanation would be that activation mechanisms are af-
fected. For example, it has been demonstrated that local anesthetics,
which block current ﬂow through Navs, produce their effect, at least
in part, by inhibiting the movement of S4 voltage-sensors once acti-
vation has occurred, thereby stabilizing Navs in an inactivation state
[18]. Another activation-dependent mechanism of Nav inhibition
which is found with some neurotoxins would be “trapping” of S4 seg-
ments in the resting state, thereby impeding activation [19]. There-
fore, although the speciﬁc mechanism for the reduction in INa in this
study is not known, it could be due to a combination of molecular
modiﬁcations of gating kinetics, including inactivation, activation, al-
losteric effects, or simply a physical blocking of the pore.
4.3. Time-dependence of MTSEA effect is independent of kinetic state for
the ﬁrst 4 min of exposure
Another interesting result from this study comes from the experi-
ments that demonstrated that MTSEA exposure for the ﬁrst 4 min is
independent of kinetic state, i.e., the inactivation-dependent decrease
in INa recorded over minutes 4–8 occurs whether or not the ﬁrst
4 min of MTSEA exposure is in closed, fast-, or slow-inactivated
hNav1.5-C373Y. One possible explanation for this result is that the
site(s) of modiﬁcation is not readily accessible to MTSEA. For exam-
ple, if the modiﬁcation is occurring intracellularly, e.g., in the intracel-
lular loops between segments and/or domains, the MTSEA would
need to cross the membrane in order to access these sites. While
MTSEA can cross the membrane, it does not do so very rapidly [10].
This would explain the relatively long time it takes to produce the
MTSEA effect. Once the MTSEA has reached the site, molecular rear-
rangement and accessibility associated with inactivation would
allow modiﬁcation, resulting in decreased INa.
4.4. Different Nav isoforms, different responses to MTSEA — hNav1.5-
C373Y vs hNav1.4
The long-term, state-dependent MTSEA-mediated reduction in INa
that we discovered in heart hNav1.5-C373Y is not found in the skele-
tal muscle hNav1.4 isoform. This result suggests that structural or ki-
netic differences in inactivation between the two Nav isoforms are
responsible for this differential response to MTSEA. A possible differ-
ence is that there are cysteine(s) in hNav1.5-C373Y that are not found
in hNav1.4. Sequence comparison between hNav1.5-C373Y and
hNav1.4 locates eleven cysteines in hNav1.5-C373Y that are absent
in hNav1.4, ten of which are found in the intracellular loops D1–D2
or D2–D3. If the MTSEA response is dependent on reaction with one
or more of these cysteines during inactivation, it could explain the
differential response of the heart vs. skeletal muscle isoform. This
hypothesis could be addressed using site-directed mutagenesis to
replace these cysteines to determine which one(s), if any, are respon-
sible for the isoform-speciﬁc differences.
An intriguing potential outcome from studies of hNav1.5-C373Y
mutants in which cysteines have been replaced would be that aspeciﬁc mutant may show an altered, e.g., reduced, response to
MTSEA, but only in one of the inactivated states, i.e., either fast or
slow. This result would suggest that there are speciﬁc molecular de-
terminants of the MTSEA-mediated effect that differ between fast
and slow inactivation that include interactions at the mutated cyste-
ine(s) residue.
In conclusion, we have demonstrated that long-term exposure to
MTSEA reduces INa in hNav1.5-C373Y in a time- and inactivated
state-dependent manner, and that this effect is not found in the Nav
isoform hNav1.4. We propose that isoform-speciﬁc conformational
determinants of inactivation underlie the difference between these
isoforms.
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